A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
We are an Artificial Intelligence (“AI”) company focused on predictive medical diagnostics. Our DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characteristics invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wounds capacity to heal or not-heal by a specified time point in the future. Our DeepView System’s output is specifically engineered to assist the physician in making a more accurate, timely and informed decision regarding the treatment of the patient’s wounds. Our focus from 2013 through 2021 was on the burn indication. We were notified that our DeepView System, comprised of the multispectral imaging (“MSI”) component integrated with the predictive AI-Burn® software component received United Kingdom Conformity Assessed (“UKCA”) marking for use in the United Kingdom for burn indications on February 22, 2024.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 23M | 30M | 18M | 25M | 1.3M |
| Net Income | -16M | -15M | -21M | -2.9M | -2.1M |
| EPS | $-0.75 | $-0.85 | $-1.48 | $-0.17 | $-0.32 |
| Free Cash Flow | 0 | -9.2M | -13M | -1.2M | -826K |
| ROIC | -38.6% | -43.0% | -95.9% | -24.3% | -1.1% |
| Gross Margin | 45.0% | 44.9% | 43.6% | 42.7% | - |
| Debt/Equity | 0.00 | -2.67 | -7.26 | 0.56 | -1.05 |
| Dividends/Share | $0.00 | - | - | - | - |
| Operating Income | -7.5M | -6.6M | -13M | -2.6M | -3.4M |
| Operating Margin | -32.2% | -22.3% | -71.9% | -10.4% | -268.8% |
| ROE | 0.0% | - | - | -24.3% | - |
| Shares Outstanding | 31M | 18M | 14M | 17M | 7M |
| Metric | 2021 | 2022 | |||
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 1.3M | 25M | 18M | 30M | 23M |
| Gross Margin | N/A | 42.7% | 43.6% | 44.9% | 45.0% |
| R&D | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -3.4M | -2.6M | -13M | -6.6M | -7.5M |
| Op. Margin | -268.8% | -10.4% | -71.9% | -22.3% | -32.2% |
| Net Income | -2.1M | -2.9M | -21M | -15M | -16M |
| Net Margin | -168.8% | -11.5% | -115.5% | -51.8% | -70.6% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||
| ROIC | -1.1% | -24.3% | -95.9% | -43.0% | -38.6% |
| ROE | N/A | -24.3% | N/A | N/A | 0.0% |
| ROA | -0.8% | -15.6% | -195.0% | -134.4% | -107.0% |
| Cash Flow | |||||
| Op. Cash Flow | -826K | -1.2M | -13M | -9.2M | -6.9M |
| Free Cash Flow | -826K | -1.2M | -13M | -9.2M | 0 |
| Owner Earnings | -826K | -2.3M | -14M | -10M | -7.9M |
| CapEx | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 0 | 11K | 9K | 10K | 10K |
| Growth CapEx | N/A | N/A | N/A | N/A | 0 |
| D&A | 0 | 11K | 9K | 10K | 10K |
| CapEx/OCF | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | N/A | 1.2M | 1.2M | 1.0M | 1.0M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||
| Net Debt | N/A | N/A | N/A | N/A | 6.6M |
| Cash & Equiv. | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | 6.6M |
| Debt/Equity | -1.05 | 0.56 | -7.26 | -2.67 | 0.00 |
| Interest Coverage | N/A | -115.1 | -447.7 | -598.4 | -598.4 |
| Equity | -21M | 12M | -1.7M | -7.3M | -8.2M |
| Total Assets | 254M | 19M | 11M | 12M | 15M |
| Total Liabilities | 22M | 6.7M | 12M | 19M | 24M |
| Intangibles | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -21M | -12M | -33M | -48M | -48M |
| Working Capital | -1.9M | 11M | -2.5M | -7.5M | -7.5M |
| Current Assets | 1.1M | 18M | 9.9M | 10M | 10M |
| Current Liabilities | 2.9M | 6.4M | 12M | 18M | 18M |
| Per Share Data | |||||
| EPS | -0.32 | -0.17 | -1.48 | -0.85 | -0.75 |
| Owner EPS | -0.12 | -0.13 | -1.03 | -0.57 | -0.26 |
| Book Value | -3.07 | 0.69 | -0.12 | -0.40 | -0.27 |
| Cash Flow/Share | -0.12 | -0.07 | -0.94 | -0.51 | -0.53 |
| Dividends/Share | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 6.8M | 17.5M | 14.1M | 18.0M | 30.7M |
| Valuation | |||||
| P/E Ratio | N/A | N/A | N/A | N/A | -2.7 |
| P/FCF | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | 14.9 | N/A | N/A | N/A |
| Price/Sales | 51.9 | 6.8 | 6.4 | 1.1 | 2.6 |
| FCF Yield | -1.2% | -0.7% | -36.6% | -18.6% | N/A |
| Market Cap | 67M | 179M | 36M | 50M | 61M |
| Avg. Price | 9.73 | 9.85 | 8.23 | 1.78 | 1.99 |
| Year-End Price | 9.86 | 10.23 | 2.57 | 2.75 | 1.99 |
Spectral AI, Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 43.7%.
Spectral AI, Inc. (MDAI) has a 5-year average return on invested capital (ROIC) of -41.1%. This is below average and may indicate limited pricing power.
Spectral AI, Inc. (MDAI) has a market capitalization of $61M. It is classified as a small-cap stock.
Spectral AI, Inc. (MDAI) does not currently pay a regular dividend.
Spectral AI, Inc. (MDAI) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
Spectral AI, Inc. (MDAI) reported annual revenue of $30 million in its most recent fiscal year, based on SEC EDGAR filings.
Spectral AI, Inc. (MDAI) has a net profit margin of -51.8%. The company is currently unprofitable.
Spectral AI, Inc. (MDAI) generated $-9 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Spectral AI, Inc. (MDAI) reported earnings per share (EPS) of $-0.85 in its most recent fiscal year.
Spectral AI, Inc. (MDAI) has a 5-year average gross margin of 43.7%. This indicates decent pricing power.
The Ledger Terminal provides 4 years of financial data for Spectral AI, Inc. (MDAI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Spectral AI, Inc. (MDAI) has a book value per share of $-0.40, based on its most recent annual SEC filing.